Oragenics

+$0.0432 (+5.72%) Today
+$0.0014 (+0.18%) As of 11:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oragenics and other ETFs, options, and stocks.

About OGEN

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains.

CEO
Michael O'Keefe Sullivan
Employees
7
Headquarters
Tampa, Florida
Founded
1996

OGEN Key Statistics

Market Cap
102.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
28.75M
High Today
$0.835
Low Today
$0.7206
Open Price
$0.74
Volume
6.94M
52 Week High
$1.80
52 Week Low
$0.377

OGEN News

BenzingaJul 27

Why Did Oragenics Shares Skyrocket Tuesday?

Oragenics Inc. (NYSE:OGEN) shares skyrocketed higher Tuesday after the company entered into a licensing agreement with the National Research Council of Canada t
BenzingaJul 27

Mid-Afternoon Market Update: Nasdaq Tumbles 240 Points; Oragenics Shares Spike Higher

Toward the end of trading Tuesday, the Dow traded down 0.50% to 34,969.30 while the NASDAQ fell 1.62% to 14,600.30. The S&P also fell, dropping 0.80% to 4,387.0

OGEN Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 13, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure